ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

31,592Medicare Part D Prescriptions Filled, Including Refills

Rank: 12 out of 676

$1.31M Total Retail Price of All Prescriptions

Rank: 24 out of 676

1,160 Patients Receiving at Least One Drug in Part D
72%Patients 65 Years and Older
63% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Mississippi
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 1,160 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

14% of this provider’s 1,160 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

2% of this provider’s 24,617 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$41 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Mississippi
FUROSEMIDE 948 783 1 4
METFORMIN HCL 932 751 2 8
OMEPRAZOLE 834 657 3 2
AMLODIPINE BESYLATE 831 673 4 3
POTASSIUM CHLORIDE 812 641 5 9
SIMVASTATIN 807 656 6 6
WARFARIN SODIUM 779 683 7 18
LEVOTHYROXINE SODIUM 672 527 8 7
ATENOLOL 665 489 9 25
CARVEDILOL 558 391 10 15
LISINOPRIL 548 427 11 5
HYDROCODONE-ACETAMINOPHEN 546 400 S3 12 1
CITALOPRAM HBR 532 442 13 17
GLIMEPIRIDE 511 375 14 30
LOVASTATIN 510 431 15 33
MELOXICAM 495 362 16 13
METOPROLOL SUCCINATE 487 384 17 14
HYDROCHLOROTHIAZIDE 433 356 18 12
PRAVASTATIN SODIUM 413 314 19 11
GABAPENTIN 403 293 20 10
RANITIDINE HCL 398 293 21 27
ENALAPRIL MALEATE 380 324 22 65
CLOPIDOGREL 365 285 23 28
AZITHROMYCIN 346 251 24 39
LISINOPRIL-HYDROCHLOROTHIAZIDE 340 233 25 16
ENALAPRIL-HYDROCHLOROTHIAZIDE 324 238 10 26 208
DONEPEZIL HCL 324 324 26 24
LANTUS 300 194 28 55
TAMSULOSIN HCL 297 274 29 38
FAMOTIDINE 269 186 30 64
ZOLPIDEM TARTRATE 268 223 31 21
ATORVASTATIN CALCIUM 267 223 32 20
TRIAMTERENE-HCTZ 263 200 33 43
NEXIUM 261 192 34 23
MIRTAZAPINE 260 243 35 59
PLAVIX 258 204 36 40
METOPROLOL TARTRATE 254 234 37 22
SERTRALINE HCL 245 178 38 26
TRAMADOL HCL 244 215 39 19
CIPROFLOXACIN HCL 242 199 40 45
TRAMADOL HCL-ACETAMINOPHEN 241 211 41 148
DIGOXIN 239 208 42 52
LOSARTAN POTASSIUM 209 157 43 34
LOSARTAN-HYDROCHLOROTHIAZIDE 203 146 44 51
NAMENDA 192 192 45 35
SPIRONOLACTONE 190 155 46 62
CYCLOBENZAPRINE HCL 189 110 R 47 50
PANTOPRAZOLE SODIUM 189 143 47 42
ISOSORBIDE MONONITRATE ER 179 138 49 54
CYMBALTA 173 141 50 47
HYDRALAZINE HCL 164 98 51 77
CEPHALEXIN 163 118 52 84
CLONIDINE HCL 159 124 53 32
SINGULAIR 158 134 54 80
BISOPROLOL-HYDROCHLOROTHIAZIDE 142 105 55 140
DIOVAN 136 134 56 37
FLUTICASONE PROPIONATE 136 116 56 49
MECLIZINE HCL 135 128 58 83
ALLOPURINOL 135 102 58 31
JANUVIA 130 108 60 78
QUETIAPINE FUMARATE 125 99 61 72
TRAZODONE HCL 124 78 62 36
AMITRIPTYLINE HCL 119 81 R 63 46
HYDROXYZINE PAMOATE 115 76 R 64 184
MUPIROCIN 108 83 65 146
AMIODARONE HCL 105 104 66 154
DIOVAN HCT 101 100 67 41
MONTELUKAST SODIUM 97 74 68 150
HUMULIN 70-30 96 50 69 209
BYSTOLIC 93 78 70 96
FELODIPINE ER 89 86 71 216
ROPINIROLE HCL 89 66 71 85
LYRICA 89 83 71 57
PROAIR HFA 88 50 74 79
METHYLPREDNISOLONE 87 64 75 124
PROMETHAZINE HCL 87 75 R 75 75
SULFAMETHOXAZOLE-TRIMETHOPRIM 87 71 75 74
TRIAMCINOLONE ACETONIDE 86 66 78 191
PREDNISONE 85 57 79 53
CLOTRIMAZOLE-BETAMETHASONE 85 56 79 170
ZETIA 85 70 79 89
CEFUROXIME 82 69 82 121
RAMIPRIL 80 66 83 86
ALENDRONATE SODIUM 79 77 84 61
AMLODIPINE BESYLATE-BENAZEPRIL 79 71 84 44
ATENOLOL-CHLORTHALIDONE 78 75 86 142
DETROL LA 78 50 86 166
BUSPIRONE HCL 77 43 88 113
PHENYTOIN SODIUM EXTENDED 75 40 89 88
KLOR-CON 10 74 68 90 95
COMBIVENT 74 67 90 174
LIPITOR 74 59 90 94
FENTANYL 73 64 S2 93 93
TIZANIDINE HCL 73 36 93 68
ADVAIR DISKUS 72 68 95 87
BENAZEPRIL HCL 72 56 95 58
NOVOLOG 70 31 97 134
PAROXETINE HCL 69 38 98 65
COLCRYS 69 58 98 122
DIVALPROEX SODIUM 68 48 100 99
KLOR-CON M20 68 35 100 67
ACTOS 66 47 102 106
AMOXICILLIN 65 46 103 105
SPIRIVA 64 63 104 97
SYMBICORT 64 62 104 189
CHLORHEXIDINE GLUCONATE 62 0 106 388
RISPERIDONE 62 34 106 69
NIFEDIPINE ER 58 46 108 100
BENICAR HCT 58 47 108 180
POLYETHYLENE GLYCOL 3350 58 37 108 56
JANUMET 57 31 111 167
AVODART 57 49 111 199
DILTIAZEM ER 56 51 113 118
EXELON 53 53 114 130
GLYBURIDE-METFORMIN HCL 53 33 R 114 76
FLUOXETINE HCL 52 51 116 70
CILOSTAZOL 52 46 116 123
CRESTOR 51 41 118 29
INSULIN SYRINGE 51 39 118 161
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.